Procaps Group, S.A Common Stock Net 2020-2023 | PROCF
Procaps Group, S.A common stock net from 2020 to 2023. Common stock net can be defined as the value of common equity ownership.
Procaps Group, S.A Annual Common Stock Net
(Millions of US $) |
| 2022 |
$379 |
| 2021 |
$379 |
| 2020 |
$56 |
| 2020 |
$0 |
| 2019 |
$ |
| 2019 |
$0 |
| 2018 |
$ |
Procaps Group, S.A Quarterly Common Stock Net
(Millions of US $) |
| 2023-09-30 |
$379 |
| 2023-06-30 |
$379 |
| 2023-03-31 |
$379 |
| 2022-12-31 |
$379 |
| 2022-09-30 |
$379 |
| 2022-06-30 |
$379 |
| 2022-03-31 |
$379 |
| 2021-12-31 |
$379 |
| 2021-09-30 |
|
| 2021-06-30 |
$0 |
| 2021-03-31 |
$0 |
| 2020-12-31 |
$56 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$0 |
| 2019-09-30 |
$0 |
| 2019-06-30 |
$0 |
| 2019-03-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
